[The antiarrhythmic effect of intravenously administered disopyramide].
J Jedlicka, S Zeman, I Málek, M Gebauerová(Institute of Clinical and Experimental Medicine), J Richterová, Stanĕk
PubMed
June 1, 1982
Cited by 0
Related Papers
A FTO variant and risk of acute coronary syndrome
|Clinica Chimica Acta|2010|65
Does angiotensin-converting enzyme polymorphism influence the clinical manifestation and progression of heart failure in patients with dilated cardiomyopathy?
|The American Journal of Cardiology|1999|32
Traditional Risk Factors of Acute Coronary Syndrome in Four Different Male Populations – Total Cholesterol Value Does Not Seem To Be Relevant Risk Factor
|Physiological Research|2017|22
Gene variants at FTO, 9p21, and 2q36.3 are age-independently associated with myocardial infarction in Czech men
|Clinica Chimica Acta|2016|20